Substance Use Screening Among Drug User

Substance Use Clinical Trial

Official title:

Screening and Brief Interventions for Substance Use in Primary Medical Institution

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02951858
• Other study ID #: JDu-003
• Status: Not yet recruiting
• Phase: N/A
• First received: October 23, 2016
• Last updated: October 31, 2016
• Start date: January 2017

Study information

• Verified date: October 2016
• Source: Shanghai Mental Health Center
• Contact: Jiang Du, M.D
• Phone: 18017311220
• Email: dujiangdou[@]163.com
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Description:

In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use. Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI). Then, the investigators will recruit 100 medical staffs to participate the training of ASSIST and BI. Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study. Finally, the investigators will collect the research information, revise the manual, and promote the training.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 218
• Est. primary completion date: December 2018
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

1. aged 18-60 years;

2. the patient to the community medical institutions;

3. ASSIST score is in 12-27, in a moderate risk;

4. voluntary to participate;

5. to agree to complete baseline interviews and follow-up studies.

Exclusion Criteria:

1. unable to complete the questionnaire;

2. serious physical illness, action inconvenience.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Substance Use

Intervention

Behavioral:
• Intervention Group
The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.
• Control Group
The participants only receive the materials about the harm of substance use.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai Mental Health Center

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Risk Behaviors measured by ASSIST questionnaire	Risk Behaviors will be measured by ASSIST questionnaire.	1 month	No
Primary	Knowledge related to Substance Use measured by Knowledge related to Addiction questionnaire	Knowledge related to substance use will be measured by Knowledge related to Addiction questionnaire.	1 month	No
Primary	Motivation measured by Pre-treatment Readiness Scale	Motivation will be measured by Pre-treatment Readiness Scale (PRS).	1 month	No
Secondary	Depression measured by Self-Rating Depression Scale	the change of depression will be measured by Self-Rating Depression Scale (SDS).	1 month	No
Secondary	Anxiety measured by Self-Rating Anxiety Scale	the change of anxiety will be measured by Self-Rating Anxiety Scale (SAS).	1 month	No
Secondary	Self-esteem measured by Self-esteem questionnaire	the change of self-esteem will be measured by Self-esteem questionnaire.	1 month	No